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CHRONIC HEART FAILURE AND DIABETES MELLITUS TYPE 2:  
QUALITY OF LIFE AND POSSIBILITY OF ITS CORRECTION
ХРОНІЧНА СЕРЦЕВА НЕДОСТАТНІСТЬ ТА ЦУКРОВИЙ ДІАБЕТ 2-ГО ТИПУ:  
ЯКІСТЬ ЖИТТЯ ТА МОЖЛИВІСТЬ ЇЇ КОРЕКЦІЇ
Abstract. Chronic heart failure of ischemic origin complicated by concomitant diabetes mellitus type 2 is character-
ized by significant decreasing of the quality of life in general, and of physical and psychological welfare, self-service 
and independence of action, same as personal implementation particularly. Inclusion of telmisartan to the scheme of 
complex treatment of the patients with chronic heart failure and diabetes mellitus type 2 results in the improvement of 
the patients’ quality of life as well as its main components.
Key words: chronic heart failure, diabetes mellitus type 2, quality of life, telmisartan.
Резюме. Хронічна серцева недостатність ішемічного генезу, ускладнена супутнім цукровим діабетом 2-го типу, 
характеризується вираженим зниженням якості життя хворих в цілому та фізичного/психологічного благополуччя, 
самообслуговування, незалежності дій та особистісної реалізації зокрема. Включення телмісартану до схеми 
комплексного лікування хворих на хронічну серцеву недостатність та цукровий діабет 2-го типу супроводжується 
вірогідним покращенням показника загального сприйняття якості життя та його основних компонентів.
Ключові слова: серцева недостатність, цукровий діабет 2-го типу, якість життя, телмісартан.
Diabetes mellitus (DM) – one of the leading medical-social problem 
of the modern society due to its high incidence, frequent comorbid-
ity with concomitant pathology, increased mortality, high risk of chronic 
vessel complications [4]. In Ukraine, same as in the world, the number 
of diabetic patients is continuously increasing mainly due to people with 
diabetes mellitus type 2, number of which totally in the population of 
the patients with this disease is around 90% (Pankiv V.I., 2010). DM is 
characterized by increased levels of blood glucose and free fatty acids, 
which is associated with the number of disorders such as central obe-
sity, dyslipidemia, increased level of plasma markers of inflammation, 
hypercoagulation with decreasing of blood fibrinolytic activity, vascu-
lar damage and hypertension. The combination of these pathological 
manifestations, known as metabolic or insulin resistance syndrome, is 
associated with high risk of cardiovascular and cerebrovascular dis-
eases [2, 3, 11].
The aim of the research was to determine the impact of chronic 
heart failure and diabetes mellitus type 2 on the quality of life of elderly 
and senile patients. 
Study design and ways of investigation. With the help of the 
modern instrumental non-invasive methods of investigation a compre-
hensive survey of 108 patients with chronic heart failure of ischemic 
origin and diabetes mellitus type 2, who were hospitalized to the car-
diological department of the Chernivtsi Regional Hospital for War Veter-
ans, was conducted. The average age of the patients was 76,04±1,84 
years. All examined patients according to their comorbidities were ran-
domized into the following subgroups: I – patients with HF without DM 
type 2 (n=32), II – patients with HF, complicated by concomitant DM 
type 2 (n=76). The control group for comparative studies comprised 24 
people without HF and DM type 2, whose age was not significantly dif-
ferent from the average age of the patients of the experimental groups.
Chronic heart failure in the examined patients was a result of coro-
nary artery disease (stable angina pectoris of II and III functional class 
(classification of the Canadian Heart Association, 1976), which was 
verified in the anamnesis due to stress tests, and post-infarction car-
diosclerosis, documented by electrocardiography before the beginning 
of the study) and corresponded IIA stage of chronic heart insufficiency 
due to the classification of M. Strazhesko and V. Vasilenko. The diagno-
sis of DM type 2 was established after corresponding examination rec-
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ommended by WHO (1999), the American Diabetes Association (1997, 
2003) and consultation of the endocrinologist. The average duration 
of diabetes was 3,2±1,11 year. All the patients had mild and moderate 
degree of the diabetes mellitus.
All patients received basic therapy of the main and concomitant dis-
eases which included beta-blockers, antithrombotic drugs, statins, ACE 
inhibitors, metabolic drugs, if necessary – nitrates, hypoglycemic drugs 
of sulfonylurea (glimepiride, glibenclamide). Moreover to achieve the 
objective of the investigation telmisartan was prescribed additionally. 
Therefore, patients with heart failure and diabetes mellitus type 2 were 
randomized into subgroups according to the prescribed treatment: IIA 
subgroup – patients who received only basic therapy (26 people); IIB 
subgroup (30 patients) – those for whom in the scheme of the standard 
treatment substitution of ACE inhibitor by angiotensin II receptor block-
er telmisartan (MIKARDIS®, Boehringer Ingelheim) was conducted. At 
the same time we want to emphasize that the standard protocol of the 
treatment of the patients with chronic heart failure and diabetes mellitus 
type 2 was not violated, as the group of patients who received opti-
mized treatment with telmisartan was constituted of the patients who 
failed to achieve compliance on the long-term usage of ACE inhibitors.
Telmisartan was prescribed in a daily dose of 40 mg after meals. 
Duration of hospital treatment was 21-24 days, in addition, it was rec-
ommended to continue treatment with telmisartan up to 3 months.
Quality of life was determined by the questionnaire Mezzich J. E., 
Cohen M., Ruiperez N. et al, 1999. 
Results of the investigation. The data obtained during question-
ing are displayed in Table 1. The level of physical welfare was the high-
est in the patients of the control group (6,2±0,56 points) dominating over 
the corresponding figure in the group of patients with chronic HF up to 
1,37 times (4,5±0,48 points, p<0,05), and up to 2,82 times (2,2±0,11 
points, p<0,05) – in patients with chronic HF and DM type 2. Value of 
the index of psychological and emotional welfare in the patients of the 
control group was 57% more than in the patients with heart failure, 
its lowest value was determined in the patients of II group – 2,1±0,25 
points, which differs significantly from the patients of the control group 
(p<0,05) and the patients of the I group (p<0,05). 
Table 1 Quality of life in patients with chronic heart failure 
with concomitant diabetes mellitus type 2 (M±SEM)
Figure Control group(n=12)
Patients with CHF 
(n=32)
Patients with 
CHF and DM 
type 2 (n=76)
Physical welfare 6,2±0,56 4,5±0,48* 2,2±0,11* # 
Psychological/
Emotional welfare 6,8±0,35 3,9±0,62* 2,1±0,25* # 
Self-service and 
independence of activity 9,4±0,62 6,3±1,11* 4,1±0,14* #
Workability 5,4±1,08 2,5±0,60* 3,8±0,09* #
Interpersonal interaction 9,3±0,31 7,2±0,54 5,6±0,37*
Socio-emotional support 8,5±1,0 6,5±1,13 3,7±0,49* #
Public support 8,6±0,65 6,4±1,03 4,6±0,32*
Personality 
implementation 7,4±0,64 5,7±0,52 2,8±0,40* #
Religious implementation 8,4±0,77 8,3±0,85 5,7±0,53
Overall perception of 
quality of life 8,0±0,33 6,1±0,64* 4,6±0,15* # 
Note: * – difference is valid comparing to the control group (p<0,05); 
# – difference is valid comparing to the patients with chronic heart fail-
ure (p<0,05)
The lowest level of self-service and independence of activity was 
detected in the patients with chronic HF and diabetes mellitus type 2 
(4,1±0,14 points), having been significantly different from the corre-
sponding value in the group of patients with heart failure of ischemic 
origin (6,3±1,11 points, p<0,05), and the control group (9,4±0,62 points, 
p<0,05) (Fig. 1).
Fig.1. Physical, psychological/emotional welfare, self-service and 
independence of activity in patients of chronic heart failure and diabe-
tes mellitus type 2
Note: * – difference is valid comparing to the control group (p<0,05); 
# – difference is valid comparing to the patients with chronic heart fail-
ure (p<0,05)
Workability index was higher in patients of both experimental 
groups than in the patients of the control group. Thus, both in the pa-
tients with isolated HF and in the patients with combined course of 
chronic HF and diabetes mellitus type 2 the difference between the 
corresponding values was statistically significant, same as comparing 
to the patients with control group (2,5±0,60 points and 3,8±0,09 points 
to 5,4±1,08 points, correspondingly, p<0,05). The level of interpersonal 
interaction and socio-emotional support was statistically significantly 
lower in comparison with the control group only in the patients of II 
experimental group. The lower value of this figure in the patients with 
chronic heart failure was statistically improbable comparing with pa-
tients of control group (Fig. 2).
Fig. 2. Workability, interpersonal interaction and socio-emotional 
support in patients of chronic heart failure and diabetes mellitus type 2
Note: * – difference is valid comparing to the control group (p<0,05); 
# – difference is valid comparing to the patients with chronic heart 
failure (p<0,05)
The level of public support in the patients of I experimental group 
was statistically improbable lower than in the control group (6,4±1,03 
against 8,6±0,65 points, p>0,05). In the patients with chronic heart 
failure and diabetes mellitus type 2 the following figure was 4,6±0,32 
points, having been statistically significantly different from the patients 
of the control group (p<0,05). Figure of the personal implementation 
was the highest in the patients of control group (7,4±0,64 points). Due 
to the chronic heart failure of ischemic origin its decreasing to 5,67±0,52 
points was determined, though we found no statistically significant dif-
ference comparing to the control group (p>0,05). The lowest level of 
personal implementation was detected in the experimental II group of 
patients with HF and DM type 2 (2,8±0,40 points, p<0,05 comparing 
with both control and I group). Index of religious implementation was 
almost equal in all investigated groups (Fig. 3.).
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Fig. 3. Public support, personal and religious implementation in 
patients of chronic heart failure and diabetes mellitus type 2
Note: * – difference is valid comparing to the control group (p<0,05); 
# – difference is valid comparing to the patients with chronic heart 
failure (p<0,05)
Comparing with the control group overall perception of quality of life 
in patients with chronic heart failure was lower by 23%, and in patients 
with heart failure and diabetes mellitus type 2 – by 42% respectively 
(p<0,05 in both cases) (Fig. 4). 
Therefore, in patients with chronic heart failure of ischemic origin 
complicated by concomitant diabetes mellitus type 2 we determined 
significant decreasing of the quality of life in general, and of physical 
and psychological welfare, self-service and independence of action, 
same as personal implementation particularly.
Fig. 4. Overall perception of quality of life in patients of chronic 
heart failure and diabetes mellitus type 2
Note: * – difference is valid comparing to the control group (p<0,05); 
# – difference is valid comparing to the patients with chronic heart fail-
ure (p<0,05)
As a result of the analysis of the quality of life of patients of both 
experimental subgroups in the dynamics of differential treatment we 
have noted its significant improvement as well as positive dynamics of 
changes of its main components (Table 2). 
Due to the table data, in the IIA experimental group during treatment 
we managed to achieve significant increasing of the figure of physical 
welfare by 59% comparing with one before treatment (p<0,001), psy-
chological and emotional welfare – by 130% (p<0,001), workability – by 
27% (p<0,02), overall perception of quality of life – by 13% respectively 
(p<0,02). Figures of self-service and independence of activity, interper-
sonal interactions, socio-emotional, public support as well as the figure 
of religious implementation as a result  of the traditional treatment un-
dergo no significant changes.
Figure 2 Quality of life in patients with chronic heart failure 
and diabetes mellitus type 2 in the dynamic of the complex treatment
Figure Control group(n=12)
Standard treatment 
(n=56)
Treatment with 
telmisartan (n=20)
Before 
treatment
After 
treatment
Before 
treatment
After 
treatment
Physical 
welfare 6,2±0,56 2,2±0,09 3,5±0,28¤ 2,3±0,13 6,4±0,34¤
Psychological/
Emotional 
welfare
6,8±0,35 2,0±0,19 4,6±0,52¤ 2,1±0,27 6,5±0,47¤
Self-service and 
independence 
of activity
9,4±0,62 4,1±0,19 4,9±0,93 4,0±0,37 5,2±1,11
Workability 5,4±1,08 3,7±0,08 4,7±0,41* 3,9±0,12 6,1±0,60¤
Interpersonal 
interaction 9,3±0,31 5,9±0,42 5,8±0,29 5,4±0,28 7,2±0,46*
Socio-emotional 
support 8,5±1,0 3,7±0,39 3,9±0,49 3,7±0,57 6,2±0,20¤
Public support 8,6±0,65 4,4±0,29 4,8±0,27 4,9±0,47 6,1±0,14*
Personality 
implementation 7,4±0,64 2,7±0,39 3,6±0,37 2,9±0,21 5,9±0,28¤
Religious 
implementation 8,4±0,77 5,6±0,48 5,9±0,22 5,9±0,53 7,4±0,39
Overall 
perception of 
quality of life
8,0±0,33 4,6±0,13 5,2±0,19* 4,7±0,11 8,2±0,33¤
Note: * – difference is significant comparing values before and after 
treatment (р<0,02); ¤ – difference is significant comparing values be-
fore and after treatment (р<0,001)
At the same time, the inclusion of telmisartan to the scheme of the 
complex treatment resulted in the statistically significant improvement 
of the overall perception of the quality of life by 1,74 times (p<0,001), 
particularly accompanied by improvement of physical welfare by 2,78 
times against corresponding value before treatment (p <0,001), psy-
chological and emotional welfare – by 3,09 times (p<0,001) and work-
ability – by 1.56 times (p<0,001), interpersonal interaction – by 1,33 
times respectively (p<0,02). In addition, in the patients of IIB group we 
have noted the improvement of the values  of socio-emotional support 
by 67% (p<0,001), public support – by 24% (p<0,02) and personal re-
alization – by 103% (p<0,001).
Conclusions. In patients with chronic heart failure of ischemic ori-
gin complicated by concomitant diabetes mellitus type 2 we determined 
significant decreasing of the quality of life in general, and of physical 
and psychological welfare, self-service and independence of action, 
same as personal implementation particularly. Inclusion of telmisartan 
to the scheme of complex treatment of the patients with chronic heart 
failure and diabetes mellitus type 2 results in the improvement of the 
patients’ quality of life as well as its main components.
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CORONARY ARTERY DISEASE, DIABETES MELLITUS TYPE 2 AND ANEMIA: CLINICAL 
PECULIARITIES OF THE COMBINED COURSE
ІШЕМІЧНА ХВОРОБА СЕРЦЯ, ЦУКРОВИЙ ДІАБЕТ 2-ГО ТИПУ ТА АНЕМІЯ:  
КЛІНІЧНІ ОСОБЛИВОСТІ ПОЄДНАНОГО ПЕРЕБІГУ
Abstract. The article deals with the clinical features of the combined course of coronary artery disease with the con-
comitant diabetes mellitus type 2 and anemia. Every fourth patient with coronary artery disease in the form of stable 
angina and concomitant diabetes mellitus type 2 does not complain for typical angina pain in the heart region during 
physical exertion, a significant part of these patients do not use nitroglycerin because of absence of typical clinical 
picture of the main disease, 30% of the patients with stable angina and diabetes mellitus type 2 do not represent the 
typical irradiation of the angina pain. Complication of coronary artery disease and diabetes by the concomitant anemia 
of different degrees of severity leads to the increasing of the daily frequency of angina, significant prevalence of pain 
irradiation and increasing of the need in anti-angina drugs.
Key words: coronary artery disease, diabetes mellitus type 2, anemia, clinical course.
